Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

被引:0
|
作者
Mehrdad Matloubian
Charles G. Lo
Guy Cinamon
Matthew J. Lesneski
Ying Xu
Volker Brinkmann
Maria L. Allende
Richard L. Proia
Jason G. Cyster
机构
[1] Immunology University of California San Francisco,Howard Hughes Medical Institute and Departments of Microbiology
[2] Medicine,Transplantation & Immunology
[3] University of California San Francisco,Genetics of Development and Disease Branch
[4] Novartis Institutes for BioMedical Research,undefined
[5] National Institute of Diabetes and Digestive and Kidney Diseases,undefined
[6] NIH,undefined
来源
Nature | 2004年 / 427卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Adaptive immunity depends on T-cell exit from the thymus and T and B cells travelling between secondary lymphoid organs to survey for antigens. After activation in lymphoid organs, T cells must again return to circulation to reach sites of infection; however, the mechanisms regulating lymphoid organ exit are unknown. An immunosuppressant drug, FTY720, inhibits lymphocyte emigration from lymphoid organs, and phosphorylated FTY720 binds and activates four of the five known sphingosine-1-phosphate (S1P) receptors1,2,3,4. However, the role of S1P receptors in normal immune cell trafficking is unclear. Here we show that in mice whose haematopoietic cells lack a single S1P receptor (S1P1; also known as Edg1) there are no T cells in the periphery because mature T cells are unable to exit the thymus. Although B cells are present in peripheral lymphoid organs, they are severely deficient in blood and lymph. Adoptive cell transfer experiments establish an intrinsic requirement for S1P1 in T and B cells for lymphoid organ egress. Furthermore, S1P1-dependent chemotactic responsiveness is strongly upregulated in T-cell development before exit from the thymus, whereas S1P1 is downregulated during peripheral lymphocyte activation, and this is associated with retention in lymphoid organs. We find that FTY720 treatment downregulates S1P1, creating a temporary pharmacological S1P1-null state in lymphocytes, providing an explanation for the mechanism of FTY720-induced lymphocyte sequestration. These findings establish that S1P1 is essential for lymphocyte recirculation and that it regulates egress from both thymus and peripheral lymphoid organs.
引用
收藏
页码:355 / 360
页数:5
相关论文
共 50 条
  • [41] Interaction of α9 integrin on medullary sinus with its ligand regulates lymphocyte egress via regulating S1P transporter, Spns2 expression and subsequent S1P secretion under inflammatory condition
    Ito, Koyu
    Matsui, Yutaka
    Kurotaki, Daisuke
    Morimoto, Junko
    Kihara, Akio
    Uede, Toshimitsu
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [42] Association of Sphingosine-1-phosphate (S1P)/S1P Receptor-1 Pathway with Cell Proliferation and Survival in Canine Hemangiosarcoma
    Rodriguez, A. M.
    Graef, A. J.
    LeVine, D. N.
    Cohen, I. R.
    Modiano, J. F.
    Kim, J. -H.
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (04) : 1088 - 1097
  • [43] PROTECTIVE EFFECTS OF SPHINGOSINE 1-PHOSPHATE (S1P) ANALOGUE AND S1P RECEPTOR 1 LIGATION IN RADIATION-INDUCED PNEUMONITIS
    Sun, X.
    Mathew, B.
    Evenoski, C.
    Moreno-Vinasco, L.
    Ma, S.
    Dudek, S. M.
    Moitra, J.
    Natarajan, V.
    Jacobson, J. R.
    Weichselbaum, R. R.
    Garcia, J. G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (03) : 550 - 551
  • [44] Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer's disease
    Jung, Younghun
    Lopez-Benitez, Jonathan
    Tognoni, Christina M.
    Carreras, Isabel
    Dedeoglu, Alpaslan
    BRAIN RESEARCH, 2023, 1799
  • [45] A role of the sphingosine-1-phosphate (S1P)-S1P receptor 2 pathway in epithelial defense against cancer (EDAC)
    Yamamoto, Sayaka
    Yako, Yuta
    Fujioka, Yoichiro
    Kajita, Mihoko
    Kameyama, Takeshi
    Kon, Shunsuke
    Ishikawa, Susumu
    Ohba, Yusuke
    Ohno, Yusuke
    Kihara, Akio
    Fujita, Yasuyuki
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27 (03) : 491 - 499
  • [46] Modulating tone: the overture of S1P receptor immunotherapeutics
    Rosen, Hugh
    Gonzalez-Cabrera, Pedro
    Marsolais, David
    Cahalan, Stuart
    Don, Anthony S.
    Sanna, M. Germana
    IMMUNOLOGICAL REVIEWS, 2008, 223 : 221 - 235
  • [47] Design and synthesis of heterocyclic S1P receptor modulators
    Li, Feng
    Cho, Hyunkyung
    Lim, Chaemin
    Choi, Ji Woong
    Kim, Sanghee
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [48] Exogenous S1P Exposure Potentiates Ischemic Stroke Damage That Is Reduced Possibly by Inhibiting S1P Receptor Signaling
    Moon, Eunjung
    Han, Jeong Eun
    Jeon, Sejin
    Ryu, Jong Hoon
    Choi, Ji Woong
    Chun, Jerold
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [49] Gating by S1P
    Dempsey, Laurie A.
    NATURE IMMUNOLOGY, 2006, 7 (08) : 801 - 801
  • [50] Biochemical prerequisites for T lymphocyte (TL) expression of the functional sphingosine 1-phosphate (S1P) G protein-coupled receptor S1P1 (Edg-1) during continuous exposure to physiological concentrations of S1P
    Goetzl, EJ
    Graeler, M
    FASEB JOURNAL, 2003, 17 (05): : A991 - A991